 |
dabrafenib and trametinib |
|---|---|
| Trade Name | Tafinlar(R) Capsules A Nd Mekinist(R) Tablets |
| Orphan Indication | Papillary thyroid cancer |
| USA Market Approval | USA |
| USA Designation Date | 2016-09-01 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corporation;1 Health Plaza, Building 337;East Hanover, New Jersey, 07936 |
